<p>The numbers of individuals who provided specimens to the DoD Serum Repository and the numbers of specimens per person.</p
Number of records published in iDigBio with at least one skeletal specimen preparation.</p
<p>The number of total participants, HRSV-positive samples by immunofluorescence, and the sequenced ...
<p>The total number of concomitant medication per study site taken by study participants during the ...
Number of serum specimens, number of contributing patients, and age of patients by specimen type.</p
<p>Numbers of specimens, of sequenced specimens and of OTUs (Sanger, NGS and total) per sample.</p
<p>Number of individuals included in the study, influenza vaccinations, and outcomes for each study ...
<p>Number of tested serum samples per age-group and collection period (percent of total).</p
<p>*Actual number of volunteers randomized in the vaccination groups.</p><p>Vaccination groups and a...
<p>Description of the number of persons included and the number of patients used in our analysis.</p
<p>The number of individuals (n = 110) identified from sampled locations using our PCR mediated iden...
The number of available subjects in each diagnostic group for annual follow-up visits.</p
<p>Number of animals studied and number of litters sampled for each experiment.</p
Number (percentage) of patients who received at least one of the drugs in the given groups.</p
<p>The proportion of patient samples that contain the different type of transcripts.</p
<p>Summary of the number and sampling locality of individuals used in the molecular analyses.</p
Number of records published in iDigBio with at least one skeletal specimen preparation.</p
<p>The number of total participants, HRSV-positive samples by immunofluorescence, and the sequenced ...
<p>The total number of concomitant medication per study site taken by study participants during the ...
Number of serum specimens, number of contributing patients, and age of patients by specimen type.</p
<p>Numbers of specimens, of sequenced specimens and of OTUs (Sanger, NGS and total) per sample.</p
<p>Number of individuals included in the study, influenza vaccinations, and outcomes for each study ...
<p>Number of tested serum samples per age-group and collection period (percent of total).</p
<p>*Actual number of volunteers randomized in the vaccination groups.</p><p>Vaccination groups and a...
<p>Description of the number of persons included and the number of patients used in our analysis.</p
<p>The number of individuals (n = 110) identified from sampled locations using our PCR mediated iden...
The number of available subjects in each diagnostic group for annual follow-up visits.</p
<p>Number of animals studied and number of litters sampled for each experiment.</p
Number (percentage) of patients who received at least one of the drugs in the given groups.</p
<p>The proportion of patient samples that contain the different type of transcripts.</p
<p>Summary of the number and sampling locality of individuals used in the molecular analyses.</p
Number of records published in iDigBio with at least one skeletal specimen preparation.</p
<p>The number of total participants, HRSV-positive samples by immunofluorescence, and the sequenced ...
<p>The total number of concomitant medication per study site taken by study participants during the ...
DOI
Add to ORKG